UBS Group’s Calliditas Therapeutics AB American Depositary Shares CALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-10,756
| Closed | -$419K | – | 9012 |
|
|
2024
Q2 | $419K | Buy |
+10,756
| New | +$419K | ﹤0.01% | 4048 |
|
|
2024
Q1 | – | Sell |
-952
| Closed | -$24.5K | – | 8800 |
|
|
2023
Q4 | $24.5K | Buy |
952
+911
| +2,222% | +$23.5K | ﹤0.01% | 5776 |
|
|
2023
Q3 | $749 | Sell |
41
-136
| -77% | -$2.48K | ﹤0.01% | 7154 |
|
|
2023
Q2 | $2.8K | Sell |
177
-129
| -42% | -$2.04K | ﹤0.01% | 6608 |
|
|
2023
Q1 | $7.34K | Sell |
306
-143
| -32% | -$3.43K | ﹤0.01% | 6717 |
|
|
2022
Q4 | $7.63K | Buy |
449
+190
| +73% | +$3.23K | ﹤0.01% | 7685 |
|
|
2022
Q3 | $4K | Sell |
259
-377
| -59% | -$5.82K | ﹤0.01% | 8324 |
|
|
2022
Q2 | $11K | Sell |
636
-854
| -57% | -$14.8K | ﹤0.01% | 6831 |
|
|
2022
Q1 | $29K | Buy |
1,490
+33
| +2% | +$642 | ﹤0.01% | 6008 |
|
|
2021
Q4 | $36K | Buy |
1,457
+1,295
| +799% | +$32K | ﹤0.01% | 6109 |
|
|
2021
Q3 | $4K | Buy |
162
+151
| +1,373% | +$3.73K | ﹤0.01% | 7553 |
|
|
2021
Q2 | $0 | Sell |
11
-680
| -98% | – | ﹤0.01% | 8680 |
|
|
2021
Q1 | $19K | Buy |
+691
| New | +$19K | ﹤0.01% | 6427 |
|
|
2020
Q4 | – | Sell |
-836
| Closed | -$20K | – | 7708 |
|
|
2020
Q3 | $20K | Buy |
+836
| New | +$20K | ﹤0.01% | 5448 |
|